Skip to content

Acute Colon Resection Versus Bridge to Colon Surgery With Stent or Stoma

Acute Colon Resection Versus Bridge to Colon Surgery With Stent or Stoma: a Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04450758
Acronym
ACBC
Enrollment
1000
Registered
2020-06-30
Start date
2020-09-01
Completion date
2031-12-31
Last updated
2026-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer

Brief summary

P) patients with acute obstructive colon cancer I) resection or bridge to surgery with stent or stoma C) emergency procedure O ) morbidity and mortality within 30 days, 90 day mortality and 3 & 5 years overall survival

Detailed description

The aim of this prospective observational study is to evaluate primary resection for malignant obstruction of the colon compared to only decompression as first intervention regarding postoperative outcomes. We hypothesize that patients with malignant obstruction benefit from avoidance of emergency cancer resection, by a two-stage procedure, with decompression by a stoma or stent as first intervention, leading to decreased short-term morbidity and mortality and improved long-term oncological outcome.

Interventions

PROCEDUREBridge to Surgery (stent or stoma)

The study is an observational study and patients will not be randomized. Resection is defined as upfront surgical resection, Bridge to Surgery as a two stage procedure.

Sponsors

Skane University Hospital
Lead SponsorOTHER
Göteborg University
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Age \>18 years * Symptomatic large bowel obstruction requiring acute intervention * CT-verified colon obstruction due to colon cancer independent of presence of metastases * Informed consent

Exclusion criteria

* Colonic perforation or bleeding * Colonic obstruction of other origin than colon cancer * Palliative situation

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with 30-day severe morbidity30 daysClavien-Dindo \>3 within 30 days postop
Overall survival after 3 years3 yearssurvival unspecified
Number of patients with 30 day mortality30 daysdeath within 30 days
Overall survival after 5 years5 yearssurvival unspecified
Number of patients with 90 day mortality90 daysdeath within 90 days

Secondary

MeasureTime frameDescription
Number of patients with locally radical resections90 daysresections regarded as R0
Number of examined mesenteric lymph nodes90 dayslymph nodes examined by pathologist
Proportion of patients receiving neoadjuvant or adjuvant treatment1 yearpatients receiveing chemotherapy
Proportion of patients with stomas after 3 years3 yearspatients with bowel continuity without stome
Recurrence rate after 3 after years3 yearsrelapse within 3 years
Disease-free survival after 3 years3 yearssurvival without disease relapse after 3 years
Proportion of patients not being subjected to resection of initially decompressed90 dayspatients not proceeding to resection
bridging interval90 daysinterval between stenting or stoma and resection
Number of stent complications (perforations, migration, bleeding, success rate etc)90 dayscomplications in stent group
Number of stoma complications90 dayscomplications in stoma group
Morbidity and survival and impact of tumour location5 years30 day morbidity and mortality depending on tumour location i.e. right or left colon
Number of laparoscopic resections90 daysnumbers of laparoscopic vs open resections
Number of primary anastomosis90 daysnumber of primary anastomosis in the Bridge to Surgery vs up front resection group
Number of stomas after resection and type of stoma90 daysnumber of stomas in Bridge to Surgery vs up front resection group
total hospital stay in days90 daysdays in hospital in Bridge to Surgery vs up front resection
colorectal surgeon performing resectional surgery90 daysqualified colorectal surgeon, general surgeon or resident performing resectional surgery

Countries

Sweden

Contacts

CONTACTPamela Buchwald, PhD MD
pamela.buchwald@med.lu.se004640331000
CONTACTCaroline Nilsson, RN
caroline.n.nilsson@skane.sese0046331000
PRINCIPAL_INVESTIGATORPamela Buchwald, PhD MD

Skåne University Hospital, Lund University

STUDY_CHAIRTobias Axmarker, MD

Skåne University Hospital, Lund University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 24, 2026